

[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
Christopher Raymond Maintained (ABBV) at Buy with Increased Target to $190 on, Jun 18th, 2024
Christopher Raymond of Piper Sandler, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $185 to $190 on, Jun 18th, 2024.
Christopher has made no other calls on ABBV in the last 4 months.
There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 0 agree with Christopher's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Christopher
- Rajesh Kumar of "HSBC" Upgraded from Hold to Strong Buy and Held Target at $185 on, Wednesday, June 5th, 2024
- Louise Chen of "Cantor Fitzgerald" Initiated at Buy and Held Target at $200 on, Friday, May 17th, 2024
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $187 on, Monday, April 29th, 2024
- Evan David Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $180 on, Monday, April 29th, 2024
- Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 22nd, 2024
Contributing Sources